Wanbury Ltd (WANBURY) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 965190, "name": "Wanbury", "stock_name": "Wanbury", "full_name": "Wanbury Ltd", "name_url": "stocks-analysis/wanbury", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "246.45", "chg": -8.4, "chgp": "-3.3%", "dir": -1, "prev_price": "254.85", "mcapval": "893.00 Cr", "mcap": "Micro Cap", "scripcode": 524212, "symbol": "WANBURY", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE107F01022", "curr_date": "Aug 10, 03:30 PM", "curr_time": "03:59 AM", "last_traded_at": "Aug 10, 03:30 PM IST", "bse_nse_vol": "5.73 lacs", "exc_status": "Active", "traded_date": "Aug 10, 2026", "traded_date_str": "2026 08 10", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/wanbury-965190-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Wanbury Ltd Falls 13.33%: Mixed Technicals and Debt Concerns Weigh on Stock", "link": "https://www.marketsmojo.com/news/stocks-in-action/wanbury-ltd-falls-1333-mixed-technicals-and-debt-concerns-weigh-on-stock-4143251", "imagepath": "", "date": "2026-08-08 14:04:33", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>3 Aug:</strong> Stock opens at ₹286.80, down 2.47% amid technical concerns</p>\n <p><strong>4 Aug:</strong> Wanbury Ltd downgraded to Hold due to mixed technicals and high debt</p>\n <p><strong>6 Aug:</strong> Continued price decline with mild technical bearishness</p>\n <p><strong>7 Aug:</strong> Sharp drop of 6.97% closes the week at ₹254.85</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.294.05</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class..." }, { "title": "When is the next results date for Wanbury Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-wanbury-ltd-4136438", "imagepath": "", "date": "2026-08-04 23:19:28", "description": "The next results date for Wanbury Ltd is scheduled for 11 August 2026...." }, { "title": "Wanbury Ltd Downgraded to Hold Amid Mixed Technicals and High Debt Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/wanbury-ltd-downgraded-to-hold-amid-mixed-technicals-and-high-debt-concerns-4135889", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/WanburyLtd_mojoScore_4135889.png", "date": "2026-08-04 09:06:45", "description": "Wanbury Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 3 August 2026. This adjustment reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technicals. Despite strong long-term growth and robust profitability metrics, concerns over elevated debt levels and a shift in technical indicators have tempered investor enthusiasm." }, { "title": "Wanbury Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/wanbury-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4135095", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/WanburyLtd_technicaldot_4135095.png", "date": "2026-08-04 08:08:32", "description": "Wanbury Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a nuanced market sentiment. Despite a recent downgrade from a Buy to a Hold rating by MarketsMOJO on 3 August 2026, the stock’s price action and technical indicators reveal a complex interplay of bullish and bearish signals that investors should carefully analyse." }, { "title": "Wanbury Ltd Upgraded to Buy on Strong Valuation and Financial Metrics", "link": "https://www.marketsmojo.com/news/stock-recommendation/wanbury-ltd-upgraded-to-buy-on-strong-valuation-and-financial-metrics-4123683", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/WanburyLtd_mojoScore_4123683.png", "date": "2026-07-28 08:52:47", "description": "Wanbury Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Hold to Buy as of 27 July 2026. This upgrade reflects a comprehensive reassessment of the company’s valuation, financial trends, quality metrics, and technical indicators, signalling renewed investor confidence amid robust operational performance and attractive market positioning." }, { "title": "Wanbury Ltd Gains 0.17%: Valuation Shift and Market Resilience Define the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/wanbury-ltd-gains-017-valuation-shift-and-market-resilience-define-the-week-4120568", "imagepath": "", "date": "2026-07-25 14:02:54", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Jul 20:</strong> Stock surged 2.38% to Rs.339.85, outperforming Sensex</p>\n <p><strong>Jul 21:</strong> MarketsMOJO downgraded Wanbury Ltd to Hold citing valuation concerns</p>\n <p><strong>Jul 22:</strong> Valuation grade shifted from attractive to fair amid sector comparison</p>\n <p><strong>Jul 24:</strong> Week ended with a modest gain of 0.80% at Rs.332.50 despite Sensex decline</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.331.95</div></div>\n <div class=\"stat-item\"><div cla..." }, { "title": "Wanbury Ltd Downgraded to Hold Amid Valuation Concerns Despite Strong Financials", "link": "https://www.marketsmojo.com/news/stock-recommendation/wanbury-ltd-downgraded-to-hold-amid-valuation-concerns-despite-strong-financials-4114664", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/WanburyLtd_mojoScore_4114664.png", "date": "2026-07-22 08:26:49", "description": "Wanbury Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 21 July 2026. This revision reflects a shift in valuation metrics alongside a nuanced assessment of the company’s financial trends, quality parameters, and technical outlook. Despite robust operational performance and impressive long-term returns, concerns over valuation and debt levels have tempered enthusiasm among investors." }, { "title": "Wanbury Ltd Valuation Shifts to Fair Amid Strong Returns and Sector Comparison", "link": "https://www.marketsmojo.com/news/stocks-in-action/wanbury-ltd-valuation-shifts-to-fair-amid-strong-returns-and-sector-comparison-4114386", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/WanburyLtd_valuationdot_4114386.png", "date": "2026-07-22 08:01:38", "description": "Wanbury Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid strong operational metrics and a competitive peer landscape, prompting investors to reassess the stock’s price attractiveness relative to historical and sector benchmarks." }, { "title": "Wanbury Ltd Gains 11.73%: 5 Key Factors Driving the Week’s Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/wanbury-ltd-gains-1173-5-key-factors-driving-the-weeks-rally-4107357", "imagepath": "", "date": "2026-07-18 14:02:22", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>13 Jul:</strong> Stock opens at Rs.300.75, modest gain amid flat Sensex</p>\n <p><strong>14 Jul:</strong> Wanbury Ltd hits new 52-week and all-time high at Rs.347.1; downgraded to Hold then upgraded back to Buy</p>\n <p><strong>15 Jul:</strong> New 52-week high at Rs.360 and all-time high at Rs.352.95; shares surge 11.75%</p>\n <p><strong>16 Jul:</strong> Slight dip to Rs.343.45 amid mixed technical momentum</p>\n <p><strong>17 Jul:</strong> Week closes at Rs.331.95, down 3.35% on the day but up for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"sta..." } ], "total": 1067, "sid": "965190", "stock_news_url": "https://www.marketsmojo.com/news/wanbury-965190" }, "announcements": [ { "caption": "Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015", "datetime": "03-Aug-2026", "details": "Wanbury Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve Notice is hereby given pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that the meeting of the Board of Directors of Wanbury Limited is scheduled to be held on Tuesday August 11 2026 inter-alia to consider and approve the Un-audited Financial Results for the first quarter and three months ended June 30 2026.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release", "datetime": "30-Jul-2026", "details": "Press Release - No DMF deficiency letter received from the office of USFDA for multiple ANDAs", "source": "BSE" }, { "caption": "Intimation Of Completion Of Inspection By The United States Food And Drug Administration (USFDA) At The Companys Facility At Tanuku West Godavari District Andhra Pradesh", "datetime": "22-Jul-2026", "details": "Intimation of completion of inspection by the United States Food and Drug Administration (USFDA) at the Companys Facilty.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "(11 Aug 2026)" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Wanbury Ltd has declared <strong>10%</strong> dividend, ex-date: 29 Jul 10", "dt": "2010-07-29", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

3 Aug: Stock opens at ₹286.80, down 2.47% amid technical concerns

4 Aug: Wanbury Ltd downgraded to Hold due to mixed technicals and high debt

6 Aug: Continued price decline with mild technical bearishness

7 Aug: Sharp drop of 6.97% closes the week at ₹254.85

Week Open

Rs.294.05

Week Close

Read full news article

When is the next results date for Wanbury Ltd?

2026-08-04 23:19:28

The next results date for Wanbury Ltd is scheduled for 11 August 2026....

Read full news article

Wanbury Ltd Downgraded to Hold Amid Mixed Technicals and High Debt Concerns

2026-08-04 09:06:45

Wanbury Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 3 August 2026. This adjustment reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technicals. Despite strong long-term growth and robust profitability metrics, concerns over elevated debt levels and a shift in technical indicators have tempered investor enthusiasm.

Read full news article

Wanbury Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-08-04 08:08:32

Wanbury Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a nuanced market sentiment. Despite a recent downgrade from a Buy to a Hold rating by MarketsMOJO on 3 August 2026, the stock’s price action and technical indicators reveal a complex interplay of bullish and bearish signals that investors should carefully analyse.

Read full news article

Wanbury Ltd Upgraded to Buy on Strong Valuation and Financial Metrics

2026-07-28 08:52:47

Wanbury Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Hold to Buy as of 27 July 2026. This upgrade reflects a comprehensive reassessment of the company’s valuation, financial trends, quality metrics, and technical indicators, signalling renewed investor confidence amid robust operational performance and attractive market positioning.

Read full news article

Wanbury Ltd Gains 0.17%: Valuation Shift and Market Resilience Define the Week

2026-07-25 14:02:54

Key Events This Week

Jul 20: Stock surged 2.38% to Rs.339.85, outperforming Sensex

Jul 21: MarketsMOJO downgraded Wanbury Ltd to Hold citing valuation concerns

Jul 22: Valuation grade shifted from attractive to fair amid sector comparison

Jul 24: Week ended with a modest gain of 0.80% at Rs.332.50 despite Sensex decline

Week Open

Rs.331.95

Read full news article

Wanbury Ltd Downgraded to Hold Amid Valuation Concerns Despite Strong Financials

2026-07-22 08:26:49

Wanbury Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 21 July 2026. This revision reflects a shift in valuation metrics alongside a nuanced assessment of the company’s financial trends, quality parameters, and technical outlook. Despite robust operational performance and impressive long-term returns, concerns over valuation and debt levels have tempered enthusiasm among investors.

Read full news article

Wanbury Ltd Valuation Shifts to Fair Amid Strong Returns and Sector Comparison

2026-07-22 08:01:38

Wanbury Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid strong operational metrics and a competitive peer landscape, prompting investors to reassess the stock’s price attractiveness relative to historical and sector benchmarks.